The accuracy of the tests detecting these antibodies and their ability to differentiate PBC patients and healthy cases was 61%, 66%, and 64% for anti-Sp140, anti-Sp100, and anti-PML, respectively, and disease prevalence was 52% for each antibody. This evidence concerns the gene SP140 and primary biliary cholangitis.